Announcement of The Announcement of the Wholly-owned Subsidiary Dalian Hanxin Hepatitis B Vaccine passing GMP Certification

Securities Code: 600873 Securities Short: Plum Biological Announcement No2014-0702NuMeihua Biotech Group Co., Ltd2Nuon the wholly-owned subsidiary Dalian Hanxin hepatitis B Vaccine2Nuthrough GMP certification announcement2Nuthe board of directors and all the directors of this announcement to ensure that there is no false record, misleading or missing the content of the notice, and its content, accuracy and non-integrity2Nu
Recently, the website of the State Food and Drug Administration issued the "State Food and Drug Administration Drug GMP Certification Notice (No32)" (The State Food and Drug Administration announced No59 of 2014)In accordance with the provisions of the Measures for the Certification of Quality Management of Pharmaceutical Production, after on-site inspection and approval, Dalian Hanxin Biopharmaceutical Co., Ltd("Dalian Hanxin") drug recombinant hepatitis B vaccine (Hanson yeast) production in line with the "Pharmaceutical Production Quality Management Practices (revised in 2010)" (Drug GMP) requirements, issued to the "Drug GMP Certificate", certification information is as follows:2NuNuCertificate Number: CN201404542NuName: Dalian Hanxin Biopharmaceutical Co., Ltd2NuAddress: Dalian Economic and Technological Development Zone, 35 Wanda Road,2NuCertification Range: Recombined Hepatitis B Vaccine (Hanson Yeast)2NuCertification Date: December 19, 20142
Valid until December 18, 2019
2Nulicensing authority: The State Food and Drug Administration2Nu hereby announces 2Nu
　　Meihua Biotech Group Co., Ltd 2Nu December 30, 2014 2Nu Securities Code: 600873 Securities: Plum Bio Announcement No: 2014-070 2Nu Meihua Biotech Group Co., Ltd 2 Nu announcement on the wholly-owned subsidiary Dalian Hanxin hepatitis B vaccine 2Nu through GMP certification
2Nu the board of directors and all the directors of this announcement to ensure that there are no false records, misleading statements or material omissions, and to bear individual and joint liability for the authenticity, accuracy and completeness of its contents 2Nu
　　Recently, the website of the State Food and Drug Administration issued the "State Food and Drug Administration Drug GMP Certification Notice (No 32)" (The State Food and Drug Administration announced No 59 of 2014) In accordance with the provisions of the Measures for the Certification of Quality Management of Pharmaceutical Production, after on-site inspection and approval, Dalian Hanxin Biopharmaceutical Co., Ltd ("Dalian Hanxin") drug recombinant hepatitis B vaccine (Hanson yeast) production in line with the "Pharmaceutical Production Quality Management Practices (revised in 2010)" (Drug GMP) requirements, issued to the "Drug GMP Certificate", certification information is as follows: 2NuNu Certificate Number: CN20140454 2Nu Name: Dalian Hanxin Biopharmaceutical Co., Ltd 2Nu Address: Dalian Economic and Technological Development Zone, 35 Wanda Road, 2Nu Certification Range: Recombined Hepatitis B Vaccine (Hanson Yeast) 2Nu Certification Date: December 19, 2014 2
　　Valid until December 18, 2019
2Nu licensing authority: The State Food and Drug Administration 2Nu hereby announces 2Nu
　　Meihua Biotech Group Co., Ltd 2Nu 20,214 2Nu shared to the feed